SELLAS Life Sciences Group Inc (FRA:RXK3)
€ 11.65 +0.55 (+4.95%) Market Cap: 2.21 Bil Enterprise Value: 2.12 Bil PE Ratio: 0 PB Ratio: 21.60 GF Score: 25/100

Sellas Life Sciences Group Inc Annual Shareholders Meeting Transcript

Jun 16, 2026 / 12:30PM GMT
Release Date Price: €6.66 (-2.06%)
Operator

Welcome to the 2026 Annual Meeting of Stockholders of Sellas Life Sciences Group, Inc., being hosted by Broadridge in a virtual format.

The meeting will commence in a moment. To get started, I introduce to you the Sellas Chair of the Board, John Varian.

John Varian
Sellas Life Sciences Group Inc - Chairman of the Board

Good morning, everyone, and welcome to the 2026 Annual Meeting of Stockholders of Sellas Life Sciences Group, Inc. I am John Varian, Chair of the company's board, and it is my pleasure to welcome each of you.

It's 8:30 AM, and in accordance with the Notice of the Meeting, I call to order the 2026 Annual Meeting of Stockholders of Sellas Life Sciences Group, Inc.

Today's meeting is a virtual meeting. Thank you very much to those who are participating in today's virtual meeting.

I call your attention to the rules of conduct for this meeting. These have been made available to each stockholder in the meeting materials section of the virtual platform.

Please adhere to the rules of conduct for your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot